Association between serum total bilirubin level and leukoaraiosis in Korean adults

Clinical Biochemistry

Volumn 45, Issue 4-5, 2012, Pages 289-292

  Park, Byoung Jin ^a   Shim, Jae Yong ^a   Lee, Hye Ree ^a   Kang, Hee Taik ^a   Lee, Jung Hyun ^b   Lee, Yong Jae ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Bilirubin; Cerebral microangiopathy; Leukoaraiosis

Indexed keywords

BILIRUBIN;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL;

EID: 84862804281     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.12.023     Document Type: Article

References (36)

1. O'Sullivan M. Leukoaraiosis. Pract Neurol 2008, 8:26-38.
2. Vernooij M.W., Ikram M.A., Tanghe H.L., Vincent A.J., Hofman A., Krestin G.P., et al. Incidental findings on brain MRI in the general population. N Eng J Med 2007, 357:1821-1828.
3. Fazekas F., Kleinert R., Offenbacher H., Schmidt R., Kleinert G., Payer F., et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993, 43:683-689.
4. Jagust W.J., Zheng L., Harvey D.J., Mack W.J., Vinters H.V., Weiner M.W., et al. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol 2008, 63:72-80.
5. Briley D.P., Wasay M., Sergent S., Thomas S. Cerebral white matter changes (leukoaraiosis), stroke, and gait disturbance. J Am Geriatr Soc 1997, 45:1434-1438.
6. Sakakibara R., Hattori T., Uchiyama T., Yamanishi T. Urinary function in elderly people with and without leukoaraiosis: relation to cognitive and gait function. J Neurol Neurosurg Psychiatry 1999, 67:658-660.
7. O'Sullivan M., Morris R.G., Huckstep B., Jones D.K., Williams S.C., Markus H.S. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004, 75:441-447.
8. Prins N.D., Van Dijk E.J., den Heijer T., Vermeer S.E., Jolles J., Koudstaal P.J., et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005, 28:2034-2041.
9. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235:1043-1046.
10. Baranano D.E., Rao M., Ferris C.D., Snyder S.H. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A 2002, 99:16093-16098.
11. Schwertner H.A., Jackson W.G., Tolan G. Association of low serum level of bilirubin with increased risk of coronary artery disease. Clin Chem 1994, 40:18-23.
12. Troughton J.A., Woodside J.V., Young I.S., Arveiler D., Amouyel P., Ferrières J., et al. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Eur J Cardiovasc Prev Rehabil 2007, 14:79-84.
13. Erdogan D., Gullu H., Yildirim E., Tok D., Kirbas I., Ciftci O., et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 2006, 184:431-437.
14. Perlstein T.S., Pande R.L., Beckman J.A., Creager M.A. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol 2008, 28:166-172.
15. Temme E.H., Zhang J., Schouten E.G., Kesteloot H. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control 2001, 12:887-894.
16. Djousse L., Levy D., Cupples L.A., Evans J.C., D'Agostino R.B., Ellison R.C. Total serum bilirubin and risk of cardiovascular disease in Framingham offspring study. Am J Cardiol 2001, 87:1196-1200.
17. Brown W.R., Moody D.M., Challa V.R., Thore C.R., Anstrom J.A. Venous collagenosis and arteriolar tortuosity in leukoaraiosis. J Neurol Sci 2002, 203-204:159-163.
18. Lammie G.A. Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002, 12:358-370.
19. Jeerakathil T., Wolf P.A., Beiser A., Massaro J., Seshadri S., D'Agostino R.B., et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham study. Stroke 2004, 35:1857-1861.
20. Inzitari D., Giordano G.P., Ancona A.L., Pracucci G., Mascalchi M., Amaducci L. Leukoaraiosis, intracerebral hemorrhage, and arterial hypertension. Stroke 1990, 21:1419-1423.
21. Brun A., Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986, 19:253-262.
22. Park K., Yasuda N., Toyonaga S., Yamada S.M., Nakabayashi H., Nakasato M. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007, 69:974-978.
23. Neuzil J., Stocker R. Free and albumin-bound bilirubin are efficient coantioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 1994, 269:16712-16719.
24. Wu T.W., Fung K.P., Wu J., Yang C.C., Weisel R.D. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol 1996, 51:859-862.
25. Lin L.Y., Kuo H.K., Hwang J.J., Lai L.P., Chiang F.T., Tseng C.D., et al. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis 2009, 203:563-568.
26. Hwang H.J., Kim S.H. Inverse relationship between fasting direct bilirubin and metabolic syndrome in Korean adults. Clin Chim Acta 2010, 411:1496-1501.
27. Madhavan M., Wattingney W.A., Srinvasan S.R., Berenson G.S. Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. Atherosclerosis 1997, 131:107-113.
28. Torgrson J.S., Lindroos A.K., Sjostrom C.D., Olsson R., Lissner L., Sjöström L. Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome?. Obes Res 1997, 5:105-114.
29. Vítek L., Schwertner H.A. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 2007, 43:1-57.
30. Ndisang J.F., Lane N., Syed N., Jadhav A. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology 2010, 151:549-560.
31. Kimm J., Yun J.E., Jo J., Jee S.H. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Stroke 2009, 40:3422-3427.
32. Endler G., Hamwi A., Sunder-Plassmann R., Exner M., Vukovich T., Mannhalter C., et al. Is low serum bilirubin an independent risk factor for coronary artery disease in men but not in women?. Clin Chem 2003, 49:1201-1204.
33. Han S.S., Na K.Y., Chae D.W., Kim Y.S., Kim S., Chin H.J. High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy. Tohoku J Exp Med 2010, 221:133-140.
34. Choi H.S., Cho Y.M., Kang J.H., Shin C.S., Park K.S., Lee H.K. Cerebral white matter hyperintensity is mainly associated with hypertension among the components of metabolic syndrome in Koreans. Clin Endocrinol 2009, 71:184-188.
35. Szolnoki Z. Reduced noncovalent connections in leukoaraiosis. Expert Rev Neurother 2008, 8:205-213.
36. Szolnoki Z., Kondacs A., Mandi Y., Bodor A., Somogyvari F. A homozygous genetic variant of mitochondrial uncoupling protein 4 affects the occurrence of leukoaraiosis. Acta Neurol Scand 2011, 123:352-357.